Category: Biopharma
Mining Stocks Hit All-Time Highs as Gold Breaks Through $3,600
Equity Insider News Commentary Issued on behalf of RUA GOLD Inc. VANCOUVER – Equity Insider News Commentary – Gold’s surge to record-breaking levels above $3,599 per ounce in September 2025[1] has catalyzed the most...
Read MoreBIOVAXYS ANNOUNCES SHARE CONSOLIDATION
Vancouver, BC, September 5, 2025 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or the “Company”) announces, further to its news release dated August 27, 2025, the consolidation of its common...
Read MoreFDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Equity Insider News Commentary – Federal budget cuts have put pressure on cancer research efforts in the United States, but private...
Read MoreBiotech Stocks Rally as Oncology Market Targets $866B by 2034
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Equity Insider News Commentary – Despite alarming federal budget cuts that stand to potentially harm the national battle against cancer, it...
Read MoreAI Just Got a Green Light from the White House—Here’s What That Means for Healthcare Stocks
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER – Equity Insider News Commentary – There’s a lot of big voices pushing for the AI revolution to make its mark, including a new plan from the...
Read MoreBiotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Equity Insider News Commentary – The average age of cancer patients is getting younger, as experts are urgently examining the rise of...
Read MoreHigh‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that looming cuts to U.S. research...
Read MoreFrom Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The AI revolution in healthcare is fully underway, with the potential to save lives and money, but there’s...
Read MoreAvant Technologies’ Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference
LAS VEGAS, NEVADA, July 22, 2025 – Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging technology company developing healthcare solutions using both artificial intelligence (AI) and developments...
Read MoreCancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Equity Insider News Commentary – As lawmakers weigh potential cuts to scientific research funding, the outlook for developing cancer cures...
Read MoreFrom Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER – Equity Insider News Commentary – Increased usage of AI in healthcare is predicted to not only save lives, but money too. However, the rollout...
Read MoreOncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers
KOL webinar to take place on July 22, 2025, at 1:00 p.m. ET SAN DIEGO, CA and CALGARY, AB, July 10, 2025 – Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for...
Read More